CORT•benzinga•June 5, 2025 at 10:08 AM

Corcept Therapeutics Presented Results From Its DAZALS Study Of Dazucorilant In Patients With ALS At The European Network To Cure ALS 2025 Annual Meeting, DAZALS Did Not Meet Its Primary Endpoint Of Improved Outcome In The Als Functional Rating Scale-revi

No summary available.

Read the full article from the original source for complete details and context.

Article published on June 5, 2025 by benzinga